1. Home
  2. MDGL vs SITM Comparison

MDGL vs SITM Comparison

Compare MDGL & SITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • SITM
  • Stock Information
  • Founded
  • MDGL 2011
  • SITM 2003
  • Country
  • MDGL United States
  • SITM United States
  • Employees
  • MDGL N/A
  • SITM N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • SITM Semiconductors
  • Sector
  • MDGL Health Care
  • SITM Technology
  • Exchange
  • MDGL Nasdaq
  • SITM Nasdaq
  • Market Cap
  • MDGL 6.1B
  • SITM 6.0B
  • IPO Year
  • MDGL N/A
  • SITM 2019
  • Fundamental
  • Price
  • MDGL $440.75
  • SITM $305.37
  • Analyst Decision
  • MDGL Strong Buy
  • SITM Strong Buy
  • Analyst Count
  • MDGL 10
  • SITM 6
  • Target Price
  • MDGL $474.67
  • SITM $258.33
  • AVG Volume (30 Days)
  • MDGL 341.0K
  • SITM 367.4K
  • Earning Date
  • MDGL 10-30-2025
  • SITM 11-05-2025
  • Dividend Yield
  • MDGL N/A
  • SITM N/A
  • EPS Growth
  • MDGL N/A
  • SITM N/A
  • EPS
  • MDGL N/A
  • SITM N/A
  • Revenue
  • MDGL $515,547,000.00
  • SITM $255,617,000.00
  • Revenue This Year
  • MDGL $394.12
  • SITM $45.98
  • Revenue Next Year
  • MDGL $57.74
  • SITM $27.05
  • P/E Ratio
  • MDGL N/A
  • SITM N/A
  • Revenue Growth
  • MDGL 3421.98
  • SITM 65.12
  • 52 Week Low
  • MDGL $200.63
  • SITM $105.40
  • 52 Week High
  • MDGL $457.16
  • SITM $308.20
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 62.88
  • SITM 74.64
  • Support Level
  • MDGL $415.53
  • SITM $272.70
  • Resistance Level
  • MDGL $440.90
  • SITM $289.33
  • Average True Range (ATR)
  • MDGL 14.27
  • SITM 11.04
  • MACD
  • MDGL -4.71
  • SITM 5.29
  • Stochastic Oscillator
  • MDGL 60.58
  • SITM 95.93

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About SITM SiTime Corporation

SiTime Corp is a provider of silicon timing systems solutions. The company designs develops and sell silicon timing systems solutions for different industries including automotive, infrastructure, aerospace-defense, consumer, internet of things, consumer and industrials. Its product offerings include Stratum 3E DCOCXOs, Programmable OCXOs, MHz Oscillators, 32.768 kHz Oscillators, Embedded Resonators, Precision MHz Super-TCXOs, and Ruggedized Oscillators. It sells its products around Taiwan, Hong Kong, the United States, and other regions and generates the majority of its revenue from Taiwan.

Share on Social Networks: